William D. Waddill, Director: Arrowhead Pharmaceuticals ARWR Sell · Filed 23/01/11

Trade details

Type: Insider sale
Amount: $96,000
Shares · price: 3,200 sh · $30.00 a share
Held after: 28,950 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: William D. WaddillDirector
Trade date: 23/01/09
Filed: 23/01/11
Days to filing: 2 days

Sold 10.0% of holdings

Share of holding sold: 10.0%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 22/12/10~23/02/08

William D. Waddill's recent trades

William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$1.1M
9,000 sh
$1.1M
Filed 06/25
Traded 06/23
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$1M
9,000 sh
$1M
Filed 06/23
Traded 06/23
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$969.1K
9,000 sh
$969.1K
Filed 06/11
Traded 06/10
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$952.8K
9,000 sh
$952.8K
Filed 06/10
Traded 06/10
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$896.8K
9,000 sh
$896.8K
Filed 06/01
Traded 05/29